Entrepreneurs

Angel investing often is the first money coming into a young company, and although it is a large segment of overall venture capital, it hasn't been tracked as closely. That's beginning to change, according to columnist Michael Rosen, and in this edition of Yer Biotech...

Scientific teams in Wisconsin and Japan have developed an ethically uncomplicated method of turning human skin cells into cells that behave like embryonic stem cells. The development, described by stem cell researcher Jamie Thomson as a game-changing event, could have significant scientific and political fallout...

Midwestern guvs met in Milwaukee last week to work on slashing greenhouse gases, but that will take a healthy business climate, not just putting ink to paper, according to columnist Tom Still. In this edition of Inside Wisconsin, he writes that technology and the markets...

Widgets of the web variety have been created for personal computing, but like other online social tools they have applications in the enterprise as well. In this edition of Buzz Networks, columnist Paul Gibler recommends them as a way to disseminate your message, build your...

The future of technology is a difficult thing to predict, but the fact that several previous forecasts already are strewn along the side of the information super highway doesn't prevent EDS futurist Jeff Wacker from making some bold predictions, or dispensing advice to chief information...

A well-drafted license agreement can be crucial to a start-up firm's successful exploitation of technology, says Madison attorney Joe Boucher. In this edition of Early Stage, Boucher notes that the significance of a license agreement extends beyond the licensor and licensee because it may be...

As a means of executive comp, the stock option - particularly the back-dated variety - has landed tech executives and companies in plenty of legal hot water. But in this Guest Column for WTN, attorney Sverre Roang offers some guidance to tech organizations that still...

Cambridge Major Laboratories continues on its expansion track with the acquisition of ChemShop B.V. of Weert Netherlands. The newly combined organization becomes one of the largest global suppliers of active pharmaceutical ingredient services. ...

The judging was tough and honest, and the lessons were many as companies seeking capital made their elevator pitches to investors during the annual Wisconsin Early-Stage Symposium. The Elevator Pitch Olympics were an opportunity for start-up companies to hone their presentations and learn from investors,...

Wisconsin's entrepreneurial and investment climate was the focus of the 2007 Early-Stage Symposium in Madison, but amid the investment pitches and the talk of what Wisconsin is doing right, there are some real concerns about how Wisconsin stacks up against other states. In particular, entrepreneurs...